Omega Healthcare Investors Inc (OHI) stock
OHINYSEReal Estate Investment TrustsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 11/3010% below fair value
$46.78−0.30 (-0.64%)
Close on Nov 17, 2026Market cap $14.17BP/E 16.9Yield 5.73%
Omega Healthcare Investors ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Omega Healthcare Investors's ebitda for the twelve months ending Sep 30, 2020 was $708.46M, down 16.0% year over year. For fiscal 2019 it was $853.43M, up 9.6% from the year before. The highest annual figure on record is $853.43M in fiscal 2019.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $853.43M | +9.6% |
| FY2018 | Dec 31, 2018 | $778.87M | +29.2% |
| FY2017 | Dec 31, 2017 | $602.77M | -27.1% |
| FY2016 | Dec 31, 2016 | $827.02M | +33.0% |
| FY2015 | Dec 31, 2015 | $621.97M | +32.7% |
| FY2014 | Dec 31, 2014 | $468.57M | +18.8% |
| FY2013 | Dec 31, 2013 | $394.33M | +20.2% |
| FY2012 | Dec 31, 2012 | $327.95M | +37.7% |
| FY2011 | Dec 31, 2011 | $238.13M | +2.0% |
| FY2010 | Dec 31, 2010 | $233.56M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $412.76M | +79.2% |
| Q2 FY2025 | Jun 30, 2025 | $361.75M | +84.2% |
| Q3 FY2020 | Sep 30, 2020 | $41.60M | -84.2% |
| Q2 FY2020 | Jun 30, 2020 | $240.11M | +20.0% |
| Q1 FY2020 | Mar 31, 2020 | $230.37M | +19.3% |
| Q4 FY2019 | Dec 31, 2019 | $196.38M | +5.2% |
| Q3 FY2019 | Sep 30, 2019 | $263.86M | +45.5% |
| Q2 FY2019 | Jun 30, 2019 | $200.16M | -1.0% |
| Q1 FY2019 | Mar 31, 2019 | $193.03M | -7.4% |
| Q4 FY2018 | Dec 31, 2018 | $186.70M | -5.9% |
| Q3 FY2018 | Sep 30, 2018 | $181.38M | – |
| Q2 FY2018 | Jun 30, 2018 | $202.29M | -4.3% |
| Q1 FY2018 | Mar 31, 2018 | $208.50M | -0.3% |
| Q4 FY2017 | Dec 31, 2017 | $198.43M | -25.9% |
| Q3 FY2017 | Sep 30, 2017 | -$16.32M | -108.5% |
| Q2 FY2017 | Jun 30, 2017 | $211.43M | – |
| Q1 FY2017 | Mar 31, 2017 | $209.22M | – |
| Q4 FY2016 | Dec 31, 2016 | $267.67M | – |
| Q3 FY2016 | Sep 30, 2016 | $192.63M | – |
See a number that looks wrong?